Higer H P
Strahlentherapie. 1981 Oct;157(10):633-42.
93 patients who had been irradiated before or after surgery of a hypernephroma were checked up in order to find secondary diseases. The three-year survival rate was 76.2% and the five-year survival rate 63.6%. 34 patients suffered from secondary diseases in the gastrointestinal tract. Sixteen patients had died, three of them because of therapy effects, six because of tumor recurrences and seven because of other factors. Two patients had local recurrences. The following risk factors for secondary diseases were found: tumor site in the right kidney, NSD over 1430-1480 ret and transperitoneal nephrectomy.
对93例肾细胞癌患者在手术前后接受过放疗的情况进行检查,以发现继发性疾病。三年生存率为76.2%,五年生存率为63.6%。34例患者患有胃肠道继发性疾病。16例患者死亡,其中3例死于治疗效果,6例死于肿瘤复发,7例死于其他因素。2例患者出现局部复发。发现以下继发性疾病的危险因素:右肾肿瘤部位、NSD超过1430 - 1480 ret以及经腹肾切除术。